Xceed TL™ is a tri-layer placental-derived allograft matrix developed using advanced processing techniques, which aims to maintain structural integrity while addressing immunogenic components.

The allograft is designed to retain extracellular matrix proteins and may serve as a natural, biologic barrier or wound cover.

Through minimal manipulation and terminal sterilization, the dehydrated allograft is processed in compliance with FDA and AATB standards.